COMMUNIQUÉS West-GlobeNewswire

Virbac: au premier semestre 2025, le chiffre d'affaires a enregistré une solide croissance de +5,6% à taux de change et périmètre constants
16/07/2025
CHIFFRES CLÉS Chiffre d’affaires du 1 er semestre 2025 738,3 M€ Croissance à taux de change et périmètre constants 1 +5,6% dont animaux de compagnie +7,1% animaux d’élevage +5,1% Croissance à taux de change constants 2 [...]
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
16/07/2025
KEY FIGURES Revenue in first half of 2025 €738.3M Growth at constant exchange rates and scope 1 +5.6 including companion animals +7.1% farm animals +5.1% Growth at constant exchange rates 2 +7.8% Overall change +5.0% [...]
eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization
16/07/2025
Miami, FL, July 16, 2025 (GLOBE NEWSWIRE) -- eMI Aesthetics , a leader in AI-driven cosmetic imaging, today announced the launch of its AI-powered aesthetic simulation platform for cosmetic treatment visualization. With [...]
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
16/07/2025
Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal of enhancing commercial viability and [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2025
16/07/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 07 juillet au 11 juillet 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2025
16/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from July 7th to July 11th 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de [...]
Bilan semestriel du contrat de liquidité avec Invest Securities
16/07/2025
Bilan semestriel du contrat de liquidité avec Invest Securities Nantes, le 16 juillet 2025, 18 heures – Au titre du contrat de liquidité confié par OSE Immunotherapeutics à Invest Securities , les moyens suivants [...]
Half-Year Report on Liquidity Contract with Invest Securities
16/07/2025
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France - July 16, 2025, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities , the following assets [...]
Constant Therapy Announces Collaboration with Burke Rehabilitation to Offer NY's First AI-Driven Post-Acute Outpatient Speech Therapy
16/07/2025
New 24/7 digital care model gives patients recovering from stroke and brain injury access to personalized speech and cognitive therapy LEXINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Constant Therapy today announced [...]
Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital
16/07/2025
CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of committed capital. Founded to address urgent unmet needs [...]
Chiesi and Plug and Play Call for Innovative Solutions to Revolutionize Respiratory Care in the U.S.
16/07/2025
Challenge invites proposals from startups who are focused on enhancing the quality of life for respiratory patients through environmentally friendly and accessible solutions CARY, N.C., July 16, 2025 (GLOBE NEWSWIRE [...]
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
16/07/2025
PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has received a [...]
Full Alliance Group Launches Development of YAHBEE SHOPPING NETWORK — A Web3-Driven, Peer-to-Peer Commerce Revolution
16/07/2025
TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), through its majority-owned subsidiary Qubitera Holdings, proudly announces the launch of the YAHBEE SHOPPING NETWORK [...]
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
16/07/2025
Commack, NY, July 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
16/07/2025
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development [...]
Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
16/07/2025
SCOTTSDALE, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has received a notification letter from the Listing Qualifications Staff of The [...]
Vystar Launches New Website and Unveils Brand Refresh www.vytex.com
16/07/2025
Boston, MA, July 16, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) Vytex manufacturer Vystar has today launched a newly-redesigned website www.vytex.com to work alongside the new brand refresh and overall [...]
TOMI Environmental Solutions Advances New Product, SteraMist Integration System – Standalone (SIS-SA)
16/07/2025
FREDERICK, Md., July 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the successful [...]
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
16/07/2025
GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment [...]

Pages